IPWatchdog.com is in the process of transitioning to a newer version of our website. Please be patient with us while we work out all the kinks.

Arun Mohan Image

Arun Mohan

is an Associate with Schiff Hardin focusing his practice on Hatch-Waxman and biosimilar patent litigation. He also brings experience as a former clinical research associate for a global contract research organization prior to pursuing his law career.

For more information or to contact Arun, please visit his Firm Profile Page.

Recent Articles by Arun Mohan

Aqua Products: Is It Helping Patent Owners Swim Better Nine Months Later?

At the time, many thought this change in law would significantly assist patentees in avoiding full-blown cancellation of their claims. However, our review suggests a case-by-case analysis without overwhelming success on a motion to amend… Although the industry expected Aqua Products to cause a sea change for motions to amend, there has been little, if any, substantive effect. Since Aqua Products, the Board has considered the opinion’s impact in 92 cases, referring to the memorandum guidance in 38. Of those 92 cases, the Board has rendered decisions in 43 cases, denying 32 motions to amend, granting in whole or in part 7 motions, and denying as moot 4 motions.